Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Open accessAbstract
Fuel Economy for Growing Cells: Sophisticated 21st-century analyses of the signaling pathways that control cell growth have led researchers back to the seminal work of Otto Warburg, who discovered in the 1920s that tumor cells generate their energy in an unusual way—by switching from mitochondrial respiration to glycolysis. The advantage conferred by this metabolic switch is puzzling because mitochondrial respiration is a more efficient way to produce ATP. Vander Heiden et al. (p. 1029 ) review arguments that rapidly growing cells have critical metabolic requirements that extend beyond ATP and that a better understanding of these requirements may shed new light on the “Warburg effect” and ultimately lead to new therapies for cancer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 68 cited sources checked · 0 supported · 0 flagged
- Findingreasoning
The 35-fold asymmetry is only partially compensated by consumption of 3 glucose molecules in acetyl-CoA production for the acyl chain carbon.
“This 35-fold asymmetry is only partially compensated by the consumption of 3 glucose molecules in acetyl-CoA production to satisfy the carbon requirement of the acyl chain itself.”
Quote in the paperSubstantial claim - Interpretationreasoning
Some glucose must be diverted to macromolecular precursors such as acetyl-CoA for fatty acids, glycolytic intermediates for nonessential amino acids, and ribose for nucleotides.
“Some glucose must be diverted to macromolecular precursors such as acetyl-CoA for fatty acids, glycolytic intermediates for nonessential amino acids, and ribose for nucleotides.”
Quote in the paperSubstantial claim - Premisecitation
Inhibiting LDH activity impairs cell proliferation.
“Inhibiting LDH activity impairs cell proliferation (6)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Fantin VR St-Pierre J Leder P Cancer Cell 9 425 2006 16766262
Not checked in the free run.
- Premisereasoning
Most carbon for fatty acid synthesis is derived from glucose.
“Most of the carbon for fatty acid synthesis is derived from glucose.”
Quote in the paperSubstantial claim - Premisecitation
Normal proliferating cells can arrest and reactivate catabolic metabolism when ATP production from glucose is compromised.
“Normal proliferating cells can also undergo cell cycle arrest and reactivate catabolic metabolism when their ability to produce ATP from glucose is compromised (12, 13)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Shaw RJ Proc Natl Acad Sci USA 101 3329 2004 14985505 PMC373461
Not checked in the free run.
- cites [13] Lum JJ Cell 120 237 2005 15680329
Not checked in the free run.
- Premisecitation
Mitochondrial function is not impaired in most cancer cells.
“subsequent work showed that mitochondrial function is not impaired in most cancer cells (5–7)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Weinhouse S Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 87 115 1976 136820
Not checked in the free run.
- cites [6] Fantin VR St-Pierre J Leder P Cancer Cell 9 425 2006 16766262
Not checked in the free run.
- cites [7] Moreno-Sanchez R Rodriguez-Enriquez S Marin-Hernandez A Saavedra E FEBS J 274 1393 2007 17302740
Not checked in the free run.
- Interpretationreasoning
The Warburg effect may provide a selective advantage at least in part by supporting biosynthetic needs.
“This may explain at least part of the selective advantage provided by the Warburg effect”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] DeBerardinis RJ Proc Natl Acad Sci USA 104 19345 2007 18032601 PMC2148292
Not checked in the free run.
- Premisereasoning
To produce two viable daughter cells, a proliferating cell must replicate all cellular contents, requiring large amounts of nucleotides, amino acids, and lipids.
“To produce two viable daughter cells at mitosis, a proliferating cell must replicate all of its cellular contents. This imposes a large requirement for nucleotides, amino acids, and lipids.”
Quote in the paperSubstantial claim - Premisecitation
Minor perturbations in the ATP/ADP ratio can impair growth.
“even minor perturbations in the ATP/ADP ratio can impair growth”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [10] Izyumov DS Biochim Biophys Acta 1658 141 2004 15282185
Not checked in the free run.
- cites [11] Vander Heiden MG Chandel NS Schumacker PT Thompson CB Mol Cell 3 159 1999 10078199
Not checked in the free run.
- Interpretationreasoning
Glucose and glutamine supply most carbon, nitrogen, free energy, and reducing equivalents for cell growth and division.
“glucose and glutamine supply most of the carbon, nitrogen, free energy, and reducing equivalents necessary to support cell growth and division”
Quote in the paperSubstantial claim- Rests on an assumption: For most mammalian cells in culture, glucose and glutamine are the only two molecules catabolized in appreciable quantities.
- Premisecitation
Most cancer cells rely on aerobic glycolysis, producing lactate even when oxygen is available, rather than primarily using mitochondrial oxidative phosphorylation.
“most cancer cells instead rely on aerobic glycolysis, a phenomenon termed “the Warburg effect.””
- Also stated in: § Proliferating Mammalian Cells Exhibit Anabolic Metabolism · plain
“most cancer cells produce large amounts of lactate regardless of the availability of oxygen and hence their metabolism is often referred to as “aerobic glycolysis.””
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] Warburg O Posener K Negelein E Biochem Z 152 319 1924
Not checked in the free run.
- cites [4] Warburg O Science 123 309 1956 13298683
Not checked in the free run.
- Also stated in: § Proliferating Mammalian Cells Exhibit Anabolic Metabolism · plain
- Interpretationcitation
ATP is likely never limiting in proliferating mammalian cells.
“there is evidence that ATP may never be limiting in these cells”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Deberardinis RJ Lum JJ Hatzivassiliou G Thompson CB Cell Metab 7 11 2008 18177721
Not checked in the free run.
- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- Interpretationreasoning
Converting all glucose to CO2 via oxidative phosphorylation to maximize ATP runs counter to the needs of a proliferating cell.
“converting all of the glucose to CO2 via oxidative phosphorylation in the mitochondria to maximize ATP production runs counter to the needs of a proliferating cell”
Quote in the paperSubstantial claim - Premisenone given
Catabolism of glutamine into lactate produces NADPH via NADP+-specific malate dehydrogenase (malic enzyme).
“the catabolism of glutamine into lactate produces NADPH via the activity of NADP+-specific malate dehydrogenase (malic enzyme)”
Quote in the paperSubstantial claim - Premisereasoning
Under high ATP/ADP and NADH/NAD+ conditions in proliferating cells, citrate is excreted into the cytosol where lipids are generated.
“Under conditions of high ATP/ADP and NADH/NAD+ exhibited by most proliferating cells, this citrate is excreted back into the cytosol where lipids are generated.”
Quote in the paperSubstantial claim - Interpretationreasoning
Elimination of excess carbon might be required to generate sufficient NADPH for proliferation.
“Elimination of excess carbon might be required to generate sufficient NADPH to support cell proliferation.”
Quote in the paperSubstantial claim - Interpretationreasoning
If bulk glucose were committed to ATP production, the resulting rise in ATP/ADP ratio would impair glycolytic flux and limit acetyl-CoA and NADPH for macromolecular synthesis.
“if this were the case, the resulting rise in the ATP/ADP ratio would severely impair the flux through glycolytic intermediates, limiting the production of the acetyl-CoA and NADPH required for macromolecular synthesis”
Quote in the paperSubstantial claim - Interpretationreasoning
Aerobic glycolytic metabolism can provide sufficient energy for cell proliferation.
“This demonstrates that aerobic glycolytic metabolism can provide sufficient energy for cell proliferation.”
Quote in the paperSubstantial claim - Premisecitation
Cells using aerobic glycolysis exhibit high ATP/ADP and NADH/NAD+ ratios.
“cells using aerobic glycolysis also exhibit high ratios of ATP/ADP (adenosine 5′-diphosphate) and NADH/NAD+ (2, 9)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Deberardinis RJ Lum JJ Hatzivassiliou G Thompson CB Cell Metab 7 11 2008 18177721
Not checked in the free run.
- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- Interpretationreasoning
For a cell to proliferate, the bulk of glucose cannot be committed to carbon catabolism for ATP production.
“It is clear that for a cell to proliferate, the bulk of the glucose cannot be committed to carbon catabolism for ATP production.”
Quote in the paperSubstantial claim - Premisecitation
Glioblastoma cells in culture convert as much as 90% of glucose and 60% of glutamine they acquire into lactate or alanine.
“glioblastoma cells in culture convert as much as 90% of glucose and 60% of glutamine they acquire into lactate or alanine (16)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] DeBerardinis RJ Proc Natl Acad Sci USA 104 19345 2007 18032601 PMC2148292
Not checked in the free run.
- Premisecitation
Amino acid and nucleotide synthesis consumes more carbon and NADPH than ATP.
“synthesis of amino acids and nucleotides also consumes more equivalents of carbon and NADPH than of ATP”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Not checked in the free run.
- Premisecitation
The low-activity form of PK-M2 is necessary for cell proliferation.
“it is the low-activity form of PK-M2 that is necessary for cell proliferation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- Premisecitation
Monoallelic mutation of the same IDH1 residue or the analogous IDH2 residue is common in gliomas, with more than 80% of indolent gliomas harboring such a mutation.
“Monoallelic mutation of the same residue in IDH1, or the analogous residue in the related enzyme IDH2, is a common feature of gliomas as more than 80% of indolent gliomas harbor such a mutation (28, 29).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In response to phosphotyrosine-protein binding, PK-M2 is induced into a low-activity state.
“In response to phosphotyrosine-protein binding, PK-M2 is induced into a low-activity state.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Christofk HR Vander Heiden MG Wu N Asara JM Cantley LC Nature 452 181 2008 18337815
Not checked in the free run.
- Premisecitation
Genes involved in glutamine metabolism appear to be under both direct and indirect transcriptional control of the MYC protein.
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Up to 12% of glioblastoma multiforme tumors harbor the same point mutation in the gene encoding cytosolic isocitrate dehydrogenase-1 (IDH1).
“up to 12% of the tumors harbor the same point mutation in the gene encoding cytosolic isocitrate dehydrogenase–1 (IDH1) (27)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Parsons DW Science 321 1807 2008 18772396 PMC2820389
Not checked in the free run.
- Premisecitation
Cellular metabolism within a tumor can be heterogeneous, with some cells using excess lactate as fuel for mitochondrial oxidative phosphorylation.
“there is emerging evidence that cellular metabolism within a tumor can be heterogeneous, with some cells using the excess lactate generated as a fuel for mitochondrial oxidative phosphorylation (19)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Sonveaux P J Clin Invest 118 3930 2008 19033663 PMC2582933
Not checked in the free run.
- Premisecitation
Proliferating cells selectively express the M2 isoform of pyruvate kinase (PK-M2).
“proliferating cells selectively express the M2 isoform of the glycolytic enzyme pyruvate kinase (PK-M2) (9)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- Interpretationreasoning
There is no selective pressure to optimize metabolism for ATP yield in most proliferating cells.
“For most proliferating cells, nutrients are not limiting so there is no selective pressure to optimize metabolism for ATP yield.”
Quote in the paperSubstantial claim- Rests on an assumption: Nutrients are not limiting for most proliferating cells.
- Interpretationreasoning
Metabolism of glucose and glutamine is orchestrated to support acetyl-CoA and NADPH production for fatty acid synthesis.
“metabolism of both glutamine and glucose is orchestrated to support the production of acetyl-CoA and NADPH needed for fatty acid synthesis”
Quote in the paperSubstantial claim - Premisecitation
In cancer patients, response to therapy is predicted by the ability to disrupt glucose metabolism as measured by FDG-PET.
“where it has been examined in cancer patients, response to therapy is predicted by the ability to disrupt glucose metabolism as measured by FDG-PET (23)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Ben-Haim S Ell P J Nucl Med 50 88 2009 19139187
Not checked in the free run.
- Premisecitation
PK-M2 is regulated by tyrosine-phosphorylated proteins.
“Unlike other pyruvate kinase isoforms, PK-M2 is regulated by tyrosine-phosphorylated proteins (17).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Christofk HR Vander Heiden MG Wu N Asara JM Cantley LC Nature 452 181 2008 18337815
Not checked in the free run.
- Premisecitation
Dependence on glutamine for survival in MYC-transformed cells is not related to ATP generation by glutamine metabolism.
“this dependence on glutamine for survival is not related to the generation of ATP by glutamine metabolism”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Yuneva M Zamboni N Oefner P Sachidanandam R Lazebnik Y J Cell Biol 178 93 2007 17606868 PMC2064426
Not checked in the free run.
- Premisecitation
PI3K pathway activation renders cells dependent on high levels of glucose flux.
“PI3K pathway activation renders cells dependent on high levels of glucose flux (20)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Buzzai M Oncogene 24 4165 2005 15806154
Not checked in the free run.
- Interpretationreasoning
This maladaptive metabolic state may underlie the evolutionary selection for induction of apoptosis and/or senescence in the setting of increased ROS.
“This maladaptive metabolic state may underlie the evolutionary selection for induction of apoptosis and/or senescence in the setting of increased ROS.”
Quote in the paperSubstantial claim - Premisecitation
Germline mutations in the TCA cycle enzymes succinate dehydrogenase and fumarate hydratase occur in some forms of human renal cell cancer, paraganglioma, and pheochromocytoma.
“Germline mutations in the TCA cycle enzymes succinate dehydrogenase and fumarate hydratase have been identified in some forms of human renal cell cancer, paraganglioma, and pheochromocytoma (24, 25).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24] Baysal BE Science 287 848 2000 10657297
Not checked in the free run.
- cites [25] Pollard PJ Wortham NC Tomlinson IP Ann Med 35 634 2003 14708972
Not checked in the free run.
- Premisecitation
Human tumor cells whose growth is driven by the MYC oncogene are particularly sensitive to glutamine withdrawal.
“Human tumor cells whose growth is driven by the MYC oncogene are particularly sensitive to glutamine withdrawal (31)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Yuneva M Zamboni N Oefner P Sachidanandam R Lazebnik Y J Cell Biol 178 93 2007 17606868 PMC2064426
Not checked in the free run.
- Premisecitation
One effect of SDH/FH mutations is activation of Hif1α-mediated glucose utilization.
“One effect of these mutations is activation of Hif1α-mediated glucose utilization (26).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Selak MA Cancer Cell 7 77 2005 15652751
Not checked in the free run.
- Interpretationreasoning
A selective pressure for rate of metabolism exists in proliferating cells.
“In contrast, a selective pressure for rate of metabolism does exist.”
Quote in the paperSubstantial claim - Premisecitation
Phosphotyrosine signaling downstream of a variety of cell growth signals shares the common ability to negatively regulate PK-M2 activity.
“Phosphotyrosine signaling downstream of a variety of cell growth signals shares the common ability to negatively regulate PK-M2 activity (17).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Christofk HR Vander Heiden MG Wu N Asara JM Cantley LC Nature 452 181 2008 18337815
Not checked in the free run.
- Premisecitation
PK-M2 is required for proliferation in vivo.
“PK-M2 is required for proliferation in vivo (9).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- Premisecitation
Glutamine uptake is critical for lipid synthesis by supplying mitochondrial oxaloacetate to maintain citrate production.
“Glutamine uptake also appears to be critical for lipid synthesis in that it supplies carbon in the form of mitochondrial oxaloacetate to maintain citrate production in the first step of the TCA cycle (16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] DeBerardinis RJ Proc Natl Acad Sci USA 104 19345 2007 18032601 PMC2148292
Not checked in the free run.
- Premisecitation
Glutamine depletion from MYC-transformed cells results in rapid loss of TCA cycle intermediates and cell death.
“Glutamine depletion from MYC-transformed cells results in the rapid loss of TCA cycle intermediates and cell death (31).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Yuneva M Zamboni N Oefner P Sachidanandam R Lazebnik Y J Cell Biol 178 93 2007 17606868 PMC2064426
Not checked in the free run.
- Interpretationreasoning
Cells that convert glucose and glutamine into biomass most efficiently proliferate fastest.
“Cells that convert glucose and glutamine into biomass most efficiently will proliferate fastest.”
Quote in the paperNot a substantial claim - Premisecitation
The PI3K signaling pathway regulates glucose uptake and utilization.
“the PI3K pathway regulates glucose uptake and utilization (Fig. 3)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Deberardinis RJ Lum JJ Hatzivassiliou G Thompson CB Cell Metab 7 11 2008 18177721
Not checked in the free run.
- Interpretationreasoning
Cells with excess nutrient uptake that have not converted to aerobic glycolysis would be predicted to have increased oxidative phosphorylation and ROS production.
“Cells with excess nutrient uptake that have not converted to aerobic glycolysis would be predicted to have increased oxidative phosphorylation and ROS production.”
Quote in the paperSubstantial claim - Premisecitation
Stationary-phase yeast lose viability when exposed to high levels of glucose and no additional nutrients.
“stationary-phase yeast lose viability when exposed to high levels of glucose and no additional nutrients (37)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] Granot D Snyder M Proc Natl Acad Sci USA 88 5724 1991 1648229 PMC51950
Not checked in the free run.
- Premisecitation
Lung tumors arising in the airways exhibit aerobic glycolysis even though these tumor cells are exposed to oxygen during tumorigenesis.
“lung tumors arising in the airways exhibit aerobic glycolysis even though these tumor cells are exposed to oxygen during tumorigenesis (9, 42)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- cites [42] Nolop KB Cancer 60 2682 1987 3499969
Not checked in the free run.
- Interpretationcitation
Cancer cells appear to use glycolytic metabolism before exposure to hypoxic conditions.
“cancer cells appear to use glycolytic metabolism before exposure to hypoxic conditions”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [40] Gottschalk S Anderson N Hainz C Eckhardt SG Serkova NJ Clin Cancer Res 10 6661 2004 15475456
Not checked in the free run.
- cites [41] Elstrom RL Cancer Res 64 3892 2004 15172999
Not checked in the free run.
- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- cites [42] Nolop KB Cancer 60 2682 1987 3499969
Not checked in the free run.
- Premisecitation
For normal proliferating tissues, signals from growth factors allow cells to utilize nutrients for growth.
“For normal proliferating tissues, such as in the developing embryo or during an immune response in the adult, signals from growth factors allow cells to utilize nutrients for growth (41, 43).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [41] Elstrom RL Cancer Res 64 3892 2004 15172999
Not checked in the free run.
- cites [43] Kondoh H Antioxid Redox Signal 9 293 2007 17184172
Not checked in the free run.
- Interpretationreasoning
The evolving evidence points to a dynamically regulated metabolic system programmed to fit the requirements for cell proliferation or the specific needs of each differentiated tissue.
“the evolving evidence instead points to a dynamically regulated system that is programmed to fit the requirements for cell proliferation or meet the specific needs of each differentiated tissue as appropriate”
Quote in the paperSubstantial claim - Interpretationcitation
Alterations in the appropriate balance of fuels and/or signal transduction pathways that deal with nutrient utilization may underlie the cancer predisposition associated with metabolic diseases such as diabetes and obesity.
“Alterations in the appropriate balance of fuels and/or signal transduction pathways that deal with nutrient utilization may underlie the cancer predisposition associated with metabolic diseases such as diabetes and obesity (45, 46).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [45] Calle EE Kaaks R Nat Rev Cancer 4 579 2004 15286738
Not checked in the free run.
- cites [46] Pollak M Nat Rev Cancer 8 915 2008 19029956
Not checked in the free run.
- Interpretationreasoning
For cancer to arise, mutations are needed to give cells the ability to acquire nutrients and coordinately regulate metabolic pathways to support proliferation.
“for cancer to arise, mutations are needed to give cells the ability to acquire nutrients and coordinately regulate metabolic pathways to support proliferation”
Quote in the paperSubstantial claim - Premisecitation
Activation of PI3K causes increased dependency on glycolysis.
“The growing evidence that activation of PI3K causes increased dependency on glycolysis”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Buzzai M Oncogene 24 4165 2005 15806154
Not checked in the free run.
- May combine two claims. 19
- Classified as probably not a substantial claim. 6
May combine two claims.
FindingreasoningTo make a 16-carbon fatty acyl chain, one glucose provides five times the ATP required, while seven glucose molecules are needed for the NADPH required.
“to make a 16-carbon fatty acyl chain, a single glucose molecule can provide five times the ATP required, whereas 7 glucose molecules are needed to generate the NADPH required”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPalmitate synthesis requires 7 ATP, 16 carbons from 8 acetyl-CoA, and 28 electrons from 14 NADPH.
“synthesis of palmitate, a major constituent of cellular membranes, requires 7 molecules of ATP, 16 carbons from 8 molecules of acetyl-CoA (coenzyme A), and 28 electrons from 14 molecules of NADPH”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Not checked in the free run.
May combine two claims.
PremisecitationSynthesis of acetyl-CoA from citrate requires ACL, and disruption of ACL impairs tumor growth.
“Synthesis of acetyl-CoA from citrate requires the enzyme ATP citrate lyase (ACL), and disruption of ACL impairs tumor growth (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Hatzivassiliou G Cancer Cell 8 311 2005 16226706
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenProliferating cells have important metabolic requirements that extend beyond ATP.
“A second possible explanation for the switch to aerobic glycolysis, discussed in detail below, is that proliferating cells have important metabolic requirements that extend beyond ATP.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationGrowth factor signaling regulates pyruvate kinase activity and modulates carbon flux through later glycolysis.
“Growth factor signaling also regulates the activity of the glycolytic enzyme pyruvate kinase and modulates flux of carbon through the later steps of glycolysis (9, 17).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] Christofk HR Nature 452 230 2008 18337823
Not checked in the free run.
- cites [17] Christofk HR Vander Heiden MG Wu N Asara JM Cantley LC Nature 452 181 2008 18337815
Not checked in the free run.
May combine two claims.
PremisecitationA glucose molecule can generate up to 36 ATP, or 30 ATP and 2 NADPH, or provide 6 carbons for macromolecular synthesis.
“A glucose molecule can generate up to 36 ATPs, or 30 ATPs and 2 NADPHs [if diverted into the pentose phosphate shunt (8, 15)], or provide 6 carbons for macromolecular synthesis.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Not checked in the free run.
- cites [15] Possibly up to four NADPH molecules per glucose can be produced if the products of the pentose phosphate shunt are metabolized via the TCA cycle and malic enzyme or cytosolic isocitrate dehydrogenase 1 (IDH1) to generate two additional NADPH molecules.
Not checked in the free run.
May combine two claims.
PremisecitationAerobic glycolysis yields only 2 ATP per glucose, while complete oxidation via oxidative phosphorylation yields up to 36 ATP.
“The metabolism of glucose to lactate generates only 2 ATPs per molecule of glucose, whereas oxidative phosphorylation generates up to 36 ATPs upon complete oxidation of one glucose molecule (8).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Not checked in the free run.
May combine two claims.
PremisecitationGlucose withdrawal induces cell death indistinguishable from growth factor withdrawal, possibly contributing to oncogene addiction.
“Glucose withdrawal induces cell death in a manner indistinguishable from that seen upon withdrawal of growth factor signaling, a phenomenon that may contribute to “oncogene addiction” (22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Vander Heiden MG Mol Cell Biol 21 5899 2001 11486029 PMC87309
Not checked in the free run.
May combine two claims.
PremisecitationPI3K signaling through AKT can regulate glucose transporter expression, enhance glucose capture by hexokinase, and stimulate phosphofructokinase activity.
“PI3K signaling through AKT can regulate glucose transporter expression, enhance glucose capture by hexokinase, and stimulate phosphofructokinase activity (2)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Deberardinis RJ Lum JJ Hatzivassiliou G Thompson CB Cell Metab 7 11 2008 18177721
Not checked in the free run.
May combine two claims.
PremisecitationSmall molecules that disrupt PI3K signaling decrease tumor glucose uptake by FDG-PET, and the ability to inhibit tumor FDG uptake correlates with tumor regression.
“Small molecules that disrupt PI3K signaling lead to decreased glucose uptake by tumors as measured by 18F-deoxyglucose positron emission tomography (FDG-PET), and the ability to inhibit tumor FDG uptake correlates with tumor regression (21).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Engelman JA Nat Med 14 1351 2008 19029981 PMC2683415
Not checked in the free run.
May combine two claims.
Premisecitationp53 expression controls metabolic genes and alters glucose utilization.
“p53 expression controls metabolic genes and alters glucose utilization”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTIGAR, a gene induced by p53, inhibits phosphofructokinase, redirects glucose toward the pentose phosphate shunt, and produces NADPH.
“Expression of TIGAR, a gene induced by p53, leads to inhibition of phosphofructokinase, redirection of glucose toward the pentose phosphate shunt, and NADPH production (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Bensaad K Cell 126 107 2006 16839880
Not checked in the free run.
May combine two claims.
InterpretationreasoningDumping excess carbon as lactate may allow faster incorporation of carbon into biomass, facilitating rapid cell division.
“Possibly the dumping of excess carbon as lactate is effective because it allows faster incorporation of carbon into biomass, which in turn facilitates rapid cell division.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOncogenic Ras causes alterations in glucose metabolism but causes senescence when expressed in cells without a cooperating oncogene.
“oncogenic Ras causes alterations in glucose metabolism (35) but causes senescence when expressed in cells without a cooperating oncogene (36)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Chiaradonna F Oncogene 25 5391 2006 16607279
Not checked in the free run.
- cites [36] Serrano M Lin AW McCurrach ME Beach D Lowe SW Cell 88 593 1997 9054499
Not checked in the free run.
May combine two claims.
PremisecitationThe Cori cycle in the liver can recycle lactate from proliferating tissues to glucose, and analogous pathways recycle alanine.
“The Cori cycle in the liver can recycle lactate generated from actively proliferating tissues to glucose, and analogous pathways exist to recycle the alanine generated from “inefficient” glutamine metabolism (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenIDH1 and IDH2 couple the interconversion of cytosolic isocitrate and α-ketoglutarate in an NADP+/NADPH-dependent reaction.
“IDH1 and IDH2 couple the interconversion of cytosolic isocitrate and α-ketoglutarate in an NADP+/NADPH-dependent reaction.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenMitochondrial oxidative phosphorylation is the major cellular source of ROS production.
“Mitochondrial oxidative phosphorylation is the major cellular source of ROS production.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLeukemic cells are highly glycolytic yet reside within the bloodstream at higher oxygen tensions than cells in most normal tissues.
“leukemic cells are highly glycolytic (40, 41), yet these cells reside within the bloodstream at higher oxygen tensions than cells in most normal tissues”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [40] Gottschalk S Anderson N Hainz C Eckhardt SG Serkova NJ Clin Cancer Res 10 6661 2004 15475456
Not checked in the free run.
- cites [41] Elstrom RL Cancer Res 64 3892 2004 15172999
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningOne function of oncogenic pathways is to drive cell-autonomous nutrient uptake and program proliferative metabolism, whereas one function of tumor suppressor pathways is to prevent nutrient utilization for anabolic processes.
“Perhaps one function of oncogenic pathways is to drive cell-autonomous nutrient uptake and program proliferative metabolism, whereas one function of tumor suppressor pathways is to prevent nutrient utilization for anabolic processes.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAvailable evidence suggests that tumor hypoxia is a late-occurring event and may not be a major contributor to the switch to aerobic glycolysis by cancer cells.
“the available evidence suggests that it is a late-occurring event that may not be a major contributor in the switch to aerobic glycolysis by cancer cells”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThere is mounting evidence for cross-talk between signaling pathways and metabolic control in every multicellular organism studied.
“There is mounting evidence for cross-talk between signaling pathways and metabolic control in every multicellular organism studied.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenMetformin and the more potent related compound Phenformin activate AMPK in cells.
“Metformin and the more potent related compound Phenformin activate AMPK in cells”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMetformin may offer a possible benefit in cancer prevention as well as improved outcomes when used with other cancer therapies.
“the widely used diabetes drug metformin may offer a possible benefit in cancer prevention as well as improved outcomes when used with other cancer therapies (44)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Evans JM Donnelly LA Emslie-Smith AM Alessi DR Morris AD BMJ 330 1304 2005 15849206 PMC558205
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenA large fraction of human cancer is dependent on aberrant signaling through the PI3K/Akt pathway.
“a large fraction of human cancer is dependent on aberrant signaling through the PI3K/Akt pathway”
Quote in the paperNot a substantial claim
The paper relies on this without support.
For most mammalian cells in culture, glucose and glutamine are the only two molecules catabolized in appreciable quantities.
“For most mammalian cells in culture, the only two molecules catabolized in appreciable quantities are glucose and glutamine.”
The paper relies on this without support.
Nutrients are not limiting for most proliferating cells.
“For most proliferating cells, nutrients are not limiting so there is no selective pressure to optimize metabolism for ATP yield.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
High levels of ROS generated by ongoing aerobic glycolysis followed by pyruvate oxidation in mitochondria (the Warburg effect) increase receptor and oncogene activity and induce genetic instability.
“high levels of ROS generated by ongoing aerobic glycolysis followed by pyruvate oxidation in mitochondria (the Warburg effect), increase receptor and oncogene activity, and the stimulation of growth factor-dependent pathways or oxidizing enzymes induce genetic instability3,4.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [3]
In “Metabolic Regulation Is a Component of the Cell Growth Machinery” (page unavailable), the paper predicts increased mitochondrial ROS in cells with excess nutrient uptake that have *not* converted to aerobic glycolysis—the opposite of the claim that aerobic glycolysis generates high ROS. It also describes oncogenes as driving glucose uptake, not ROS as increasing oncogene activity. The section does link ROS to DNA damage, but not through the claimed pathway. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredMetabolic phenotype of immortalized cell lines may diverge from native metabolic profile of their tissue of origin.
“As a result, the metabolic phenotype of immortalized cell lines may diverge from the native metabolic profile of their tissue of origin (Vander Heiden et al. 2009;Liberti and Locasale 2016).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Vander Heiden et al. 2009
The section “Proliferating Mammalian Cells Exhibit Anabolic Metabolism” contrasts the metabolism of most cancer cells with that of differentiated tissues. The section “What Triggers the Switch from Oxidative Phosphorylation to Aerobic Glycolysis?” likewise describes metabolism changing with proliferation or tissue-specific needs. Neither passage specifically addresses immortalized cell lines or compares them with their tissues of origin. (LLM, conf=0.82)
Experimental — accuracy not yet measuredAugmentation of aerobic glycolysis could aid in the mitigation of reactive oxygen species and facilitate the production of a greater quantity of amino acids to support protein synthesis in osteoblasts.
“Moreover, the augmentation of aerobic glycolysis could aid in the mitigation of reactive oxygen species and additionally facilitate the production of a greater quantity of amino acids to support protein synthesis in osteoblasts [58].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [58]
In “Metabolic Regulation Is a Component of the Cell Growth Machinery” (page not available), the paper predicts greater ROS production in cells that have not switched to aerobic glycolysis. In “Crunching the Numbers” (page not available), it explains how glycolytic intermediates can supply precursors for amino acid synthesis. These passages discuss proliferating cells generally, not osteoblasts, and do not establish increased amino acid production or protein synthesis in osteoblasts. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe ATP necessary for fungal cell growth and function is synthesized mainly through oxidative phosphorylation (OXPHOS), with the key enzyme being F1Fo-ATP synthase.
“The ATP that is necessary for fungal cell growth and function is synthesized mainly through oxidative phosphorylation (OXPHOS), with the key enzyme being F1Fo-ATP synthase4.”
From The δ subunit of F1Fo-ATP synthase is required for pathogenicity of Candida albicans (2021) · cites this paper as [4]
The section “Why Do Proliferating Cells Switch to a Less Efficient Metabolism?” says oxidative phosphorylation can produce ATP, but also says many unicellular organisms proliferate using fermentation. The paper does not establish that fungal cells obtain most of their ATP through OXPHOS or identify F1Fo-ATP synthase as the key enzyme. (LLM, conf=0.87)
Experimental — accuracy not yet measuredPI3K signaling may be central to linking common genetic perturbations of cancer, such as RTK mutations and PTEN loss, with altered metabolic processes, including the lipogenic phenotype common to many cancers, including GBM.
“PI3K signaling may be central to linking the common genetic perturbations of cancer, such as RTK mutations and PTEN loss, with altered metabolic processes, including the “lipogenic phenotype” common to many cancers, including GBM (13, 14, 17, 20).”
From An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway (2011) · cites this paper as [17]
“Metabolic Regulation Is a Component of the Cell Growth Machinery” links PI3K signaling to growth control and glucose metabolism. “Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?” describes fatty-acid synthesis, but our copy does not link PI3K to a lipogenic phenotype or establish the claimed connection through RTK mutations and PTEN loss, including in GBM. The indexed passages provide no page numbers. (LLM, conf=0.85)
Experimental — accuracy not yet measured
This metabolic reprogramming supports rapid and sustained proliferation by generating ATP, maintaining redox homeostasis, and diverting glycolytic intermediates into biosynthetic pathways required for macromolecular synthesis.
“This metabolic reprogramming supports rapid and sustained proliferation by generating ATP, maintaining redox homeostasis, and diverting glycolytic intermediates into biosynthetic pathways required for macromolecular synthesis (Vander Heiden et al. 2009;Liberti and Locasale 2016).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Vander Heiden et al. 2009
CR may also influence underlying metabolic state of primary cells, as sustained proliferation is generally associated with changes in growth- and survival-related signaling, biosynthetic demand, oxidative state, and energy use.
“In addition to these transcriptional and epigenetic concerns, CR may also influence the underlying metabolic state of primary cells, as sustained proliferation is generally associated with changes in growth-and survival-related signaling, biosynthetic demand, oxidative state, and energy use (Vander Heiden et al. 2009;Hoxhaj and Manning 2020).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Vander Heiden et al. 2009
Tumor suppressor pathways such as p53 and LKB1/AMPK signaling also regulate cellular metabolism.
“Furthermore, tumor suppressor pathways such as p53 and LKB1/ AMPK signaling also regulate cellular metabolism (Vander Heiden et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Vander Heiden et al., 2009
Cancer cells preferentially metabolize glucose by aerobic glycolysis, the Warburg effect.
“Cancer cells preferentially metabolize glucose by aerobic glycolysis, a phenomenon known as the Warburg effect.”
From An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway (2011) · cites this paper as [17]
The Warburg effect, a preference for glycolysis and lactate secretion when oxygen is present, is under cell-autonomous control by oncogenes in many proliferating cancer cells and tumors.
“The Warburg effect, a preference for glycolysis and lactate secretion in the presence of oxygen, is an example of a metabolic property under cell-autonomous control by oncogenes in many proliferating cancer cells and tumors (1).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [1]
Cancer cells metabolize glucose differently than cells of normal tissues: even in conditions of sufficient oxygen availability, cancer cells convert glucose into lactate instead of using glucose for OXPHOS.
“In 1924, Otto Warburg discovered that cancer cells metabolize glucose differently than cells of normal tissues: that even in conditions of sufficient oxygen availability, cancer cells convert glucose into lactate instead of using glucose for OXPHOS (208).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [208]
The carbon economy of a proliferating cell differs dramatically from that of a quiescent cell.
“The carbon economy of a proliferating cell differs dramatically from that of a cell that is quiescent”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Vander Heiden et al., 2009
In healthy tissue, the fate of pyruvate depends on oxygen availability and mitochondrial respiratory capacity.
“In healthy tissue, the fate of pyruvate is dependent on oxygen availability and mitochondrial respiratory capacity.14”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [14]
Cancer cells rewire glucose metabolism for lactate synthesis even in normoxia, known as the Warburg Effect.
“Otto Warburg observed that cancer cells rewire glucose metabolism for lactate synthesis even in normoxia, known as the Warburg Effect.14,21”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [14]
Many cancers depend on glycolysis for energy, creating a high requirement for glucose.
“The recent resurgence of interest in the Warburg hypothesis and cancer energetics (66) emphasizes the dependence of many cancers on glycolysis for energy, creating a high requirement for glucose (or even “glucose addiction”), since ATP generation by glycolysis requires far more glucose than oxidative phosphorylation.”
From Diabetes and Cancer (2010) · cites this paper as [66]
Aerobic glycolysis (the Warburg effect) is a common trait of actively proliferating cells.
“This process, also known as the Warburg effect from earlier work in cancer biology, is a common trait of actively proliferating cells (5).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [5]
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works
<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · see citing works
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,073 · see citing works
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784 · see citing works
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · see citing works
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613 · see citing works
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · see citing works
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622 · see citing works
Self-citationCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · see citing works
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · see citing works
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,207 · see citing works
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · see citing works
Self-citationInsulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · see citing works
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · see citing works
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works
Self-citationShaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797 · see citing works
Self-citationMutations in <i>SDHD</i> , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · see citing works
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · see citing works
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,633 · see citing works
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487 · see citing works
Self-citationAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454 · see citing works
Self-citationEngelman, J. A., Chen, L., Tan, X., Crosby, K., Guimaraes, A. R., Upadhyay, R., Maira, M., McNamara, K., Perera, S. A., Song, Y., et al. (2008) · Nature Medicine · doi:10.1038/nm.1890 · Cited by 1,330 · see citing works
Self-citationATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086 · see citing works
Self-citationEnergy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, Á., & Saavedra, E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,086 · see citing works
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995 · see citing works
Self-citationDeficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · see citing works
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536 · see citing works
Self-citationHeiden, M. G. V., Chandel, N. S., Schumacker, P. T., & Thompson, C. B. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80307-x · Cited by 505 · see citing works
Self-citationBleeker, F. E., Lamba, S., Leenstra, S., Troost, D., Hulsebos, T. J. M., Vandertop, W. P., Frattini, M., Molinari, F., Knowles, M. A., Cerrato, A., et al. (2009) · Human Mutation · doi:10.1002/humu.20937 · Cited by 365 · see citing works
Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208622 · Cited by 357 · see citing works
Self-citation18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
Ben‐Haim, S., & Ell, P. J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.054205 · Cited by 354 · see citing works
A High Glycolytic Flux Supports the Proliferative Potential of Murine Embryonic Stem Cells
Kondoh, H., Lleonart, M. E., Nakashima, Y., Yokode, M., Tanaka, M., Bernard, D., Gil, J., & Beach, D. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1467 · Cited by 325 · see citing works
Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells
Gottschalk, S., Anderson, N., Hainz, C., Eckhardt, S., & Serkova, N. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0039 · Cited by 256 · see citing works
Chen, Z., Odstrcil, E. A., Tu, B. P., & McKnight, S. L. (2007) · Science · doi:10.1126/science.1140958 · Cited by 234 · see citing works
The Warburg hypothesis fifty years later
Weinhouse, S. (1976) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00284370 · Cited by 229 · see citing works
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213 · see citing works
Self-citation“Wages of Fear”: transient threefold decrease in intracellular ATP level imposes apoptosis
Izyumov, D. S., Avetisyan, A. V., Pletjushkina, O. Y., Sakharov, D. V., WIRTZ, K. W. A., Chernyak, B. V., & Skulachev, V. P. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.05.007 · Cited by 179 · see citing works
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159 · see citing works
Ras-dependent carbon metabolism and transformation in mouse fibroblasts
Chiaradonna, F., Sacco, E., Manzoni, R., Giorgio, M., Vanoni, M., & Alberghina, L. (2006) · Oncogene · doi:10.1038/sj.onc.1209528 · Cited by 109 · see citing works
由紀子, 冨., & Snyder, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5724 · Cited by 103 · see citing works
El‐Maghrabi, M. R., & Pilkis, S. J. (1984) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240260102 · Cited by 72 · see citing works
Bleeker, F. E., Lamba, S., Rodolfo, M., Scarpa, A., Leenstra, S., Vandertop, W. P., & Bardelli, A. (2009) · Human Mutation · doi:10.1002/humu.20927 · Cited by 49 · see citing works
State of the art in comparative cancer clinical trials
Begg, C. B., Pocock, S., Freedman, L. S., & Zelen, M. (1987) · Cancer · doi:10.1002/1097-0142(19871201)60:11 · Cited by 20 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Warburg O., Posener K., Negelein E., Biochem. Z. 152, 319 (1924).
- Sonveaux P., et al.., J. Clin. Invest. 118, 3930 (2008).Medline
Cited by
Sorted by citations
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works
Self-citationThe Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · see citing works
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · see citing works
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · see citing works
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479 · see citing works
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427 · see citing works
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · see citing works
Self-citationAerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057 · see citing works
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · see citing works
Juan, C. A., Pérez de la Lastra, J. M., Plou, F. J., & Pérez-Lebeña, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094642 · Cited by 2,810 · see citing works
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740 · see citing works
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · see citing works
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2020) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,546 · see citing works
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,489 · see citing works
Dibner, C., Schibler, U., & Albrecht, U. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135821 · Cited by 2,421 · see citing works
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445 · see citing works
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366 · see citing works
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · see citing works
Dysregulated pH: a perfect storm for cancer progression
Webb, B. A., Chimenti, M. S., Jacobson, M. P., & Barber, D. L. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3110 · Cited by 2,246 · see citing works
ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176 · see citing works
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova‐Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,158 · see citing works
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · see citing works
“The metabolic changes associated with T cell activation are reminiscent of the characteristic metabolic activities of tumor cells and may represent a general metabolic reprogramming during cell growth and proliferation (Kim and Dang, 2006; Vander Heiden et al., 2009; Warburg, 1956).”
BackgroundOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043 · see citing works
Self-citationMicroglial <scp>M1/M2</scp> polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · see citing works
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990 · see citing works
Self-citationEpidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee, P., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050052 · Cited by 2,027 · see citing works
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,014 · see citing works
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997 · see citing works
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,982 · see citing works
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects
Christakos, S., Dhawan, P., Verstuyf, A., Verlinden, L., & Carmeliet, G. (2015) · Physiological Reviews · doi:10.1152/physrev.00014.2015 · Cited by 1,965 · see citing works
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926 · see citing works
The multifaceted contributions of mitochondria to cellular metabolism
Spinelli, J. B., & Haigis, M. C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0124-1 · Cited by 1,935 · see citing works
Cancer metabolism: looking forward
Martínez‐Reyes, I., & Chandel, N. S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,851 · see citing works
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831 · see citing works
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · see citing works
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · see citing works
Self-citationRecent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813 · see citing works
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775 · see citing works
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · see citing works
Glucose feeds the TCA cycle via circulating lactate
Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W., Esparza, L. A., Reya, T., Zhan, L., Yanxiang Guo, J., et al. (2017) · Nature · doi:10.1038/nature24057 · Cited by 1,721 · see citing works
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692 · see citing works
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3557 · Cited by 1,669 · see citing works
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638 · see citing works
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3803 · Cited by 1,643 · see citing works
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612 · see citing works
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589 · see citing works
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Bock, K. D., Γεωργιάδου, Μ., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,559 · see citing works
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528 · see citing works
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505 · see citing works
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418 · see citing works
Self-citationMitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Buck, M. D., O’Sullivan, D., Geltink, R. I. K., Curtis, J. D., Chang, C., Sanin, D. E., Qiu, J., Kretz, O., Braas, D., van der Windt, G. J. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.035 · Cited by 1,444 · see citing works
Targeting cancer metabolism: a therapeutic window opens
Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,409 · see citing works
LeBleu, V. S., O’Connell, J. T., Herrera, K. N. G., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A. S., Chinen, L. T. D., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,412 · see citing works
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391 · see citing works
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,381 · see citing works
Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease
Cao, S. S., & Kaufman, R. J. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5851 · Cited by 1,370 · see citing works
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363 · see citing works
Santos, C. R., & Schulze, A. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08644.x · Cited by 1,344 · see citing works
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328 · see citing works
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3483 · Cited by 1,316 · see citing works
Self-citationActivated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Guo, J. Y., Chen, H.-Y., Mathew, R., Fan, J., Strohecker, A. M., Karsli-Uzunbas, G., Kamphorst, J. J., Chen, G., Lemons, J. M. S., Karantza, V., et al. (2011) · Genes & Development · doi:10.1101/gad.2016311 · Cited by 1,323 · see citing works
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,304 · see citing works
Zong, W., Rabinowitz, J. D., & White, E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.011 · Cited by 1,287 · see citing works
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G., & Galluzzi, L. (2017) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,292 · see citing works
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243 · see citing works
van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F. M., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,251 · see citing works
The Acidic Tumor Microenvironment as a Driver of Cancer
Boedtkjer, E., & Pedersen, S. F. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034627 · Cited by 1,248 · see citing works
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,192 · see citing works
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,190 · see citing works
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., et al. (2011) · Science · doi:10.1126/science.1211485 · Cited by 1,196 · see citing works
Self-citationTargeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189 · see citing works
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179 · see citing works
Targeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,173 · see citing works
ROS homeostasis and metabolism: a dangerous liason in cancer cells
Panieri, E., & Santoro, M. M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.105 · Cited by 1,156 · see citing works
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088 · see citing works
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080 · see citing works
Macintyre, A. N., Gerriets, V. A., Nichols, A., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,129 · see citing works
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118 · see citing works
Metabolic regulation of cell growth and proliferation
Zhu, J., & Thompson, C. B. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0123-5 · Cited by 1,106 · see citing works
Self-citationYuan, M., Breitkopf, S. B., Yang, X., & Asara, J. M. (2012) · Nature Protocols · doi:10.1038/nprot.2012.024 · Cited by 1,122 · see citing works
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120 · see citing works
Self-citationGlucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095 · see citing works
Quantitative flux analysis reveals folate-dependent NADPH production
Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., & Rabinowitz, J. D. (2014) · Nature · doi:10.1038/nature13236 · Cited by 1,114 · see citing works
Self-citationAntitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068 · see citing works
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,105 · see citing works
CD8+ T Cells: Foot Soldiers of the Immune System
Zhang, N., & Bevan, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.010 · Cited by 1,102 · see citing works
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084 · see citing works
Serine and glycine metabolism in cancer
Amelio, I., Cutruzzolà, F., Antonov, A., Agostini, M., & Melino, G. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.004 · Cited by 1,056 · see citing works
Diabetes and Cancer: A Consensus Report
Giovannucci, E. L., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,065 · see citing works
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., & Lu, Z. (2011) · Nature · doi:10.1038/nature10598 · Cited by 1,033 · see citing works
Cárdenas, C., Miller, R. A., Smith, I., Bui, T., Molgó, J., Müller, M., Vais, H., Cheung, K.-H., Yang, J., Parker, I., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.007 · Cited by 1,026 · see citing works
Self-citationHarris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993 · see citing works
Metabolic requirements for the maintenance of self-renewing stem cells
Ito, K., & Suda, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3772 · Cited by 1,014 · see citing works
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R. E., Vadysirisack, D. D., Guimaraes, A., Marinelli, B., Wikstrom, J. D., Nir, T., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.041 · Cited by 1,001 · see citing works
- Authors
- Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B.
- Affiliations
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
- Harvard University (US)
- Abramson Cancer Center (US)
- Corresponding author
- Cantley, Lewis C.
- Thompson, Craig B.
- Venue
- Science
- Published
- 2009-05-22
- Volume
- 324
- Issue
- 5930
- Pages
- 1029-1033
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2849637
- OpenAlex
- W2097259163
- Semantic Scholar
- 5a3b09333eb2968904933e726dc29625e10eb188
- Cited by
- 16,197
- References
- 47
- Citations by year
- 2026: 969 · 2025: 1224 · 2024: 1225 · 2023: 1156 · 2022: 1351 · 2021: 1439 · 2020: 1276 · 2019: 1065 · 2018: 1028 · 2017: 1027 · 2016: 921 · 2015: 823 · 2014: 727 · 2013: 665 · 2012: 535
- FWCI
- 27.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA092660, R01CA105463, T32CA009172)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- Warburg effect, aerobic glycolysis, cancer metabolism, cell proliferation, mitochondrial oxidative phosphorylation, ATP production, signaling pathways, cancer-associated mutations, growth regulation
- MeSH terms
- Adenosine Triphosphate, Aerobiosis, Amino Acids, Animals, Glucose, Glycolysis, Humans, Lipids, Mutation, Neoplasms, Nucleotides, Oxidative Phosphorylation, Signal Transduction, Cell Proliferation, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review